DK2957280T3 - PHARMACEUTICAL SOLID COMPOSITION OF CYTISIN AND PROCEDURES FOR PREPARING THEREOF - Google Patents

PHARMACEUTICAL SOLID COMPOSITION OF CYTISIN AND PROCEDURES FOR PREPARING THEREOF Download PDF

Info

Publication number: DK2957280T3
Authority: DK; Denmark
Prior art keywords: cytisin; procedures; preparing; solid composition; pharmaceutical solid
Prior art date: 2014-06-18

Application number

DK15001790.3T

Other languages

Danish (da)

Inventor

Katarzyna Berdzinska

Hanna Kieronska

Marek Milewski

Malgorzata Nawrocka

Marta Klepczynska

Original Assignee

Bonteque Consulting Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-06-18

Filing date

2015-06-17

Publication date

2019-07-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54011933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2957280(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-06-17 Application filed by Bonteque Consulting Ltd filed Critical Bonteque Consulting Ltd

2019-07-22 Application granted granted Critical

2019-07-22 Publication of DK2957280T3 publication Critical patent/DK2957280T3/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK15001790.3T 2014-06-18 2015-06-17 PHARMACEUTICAL SOLID COMPOSITION OF CYTISIN AND PROCEDURES FOR PREPARING THEREOF DK2957280T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL408608A PL408608A1 (en)	2014-06-18	2014-06-18	Stable permanent pharmaceutical composition of cytisine and method for producing it

Publications (1)

Publication Number	Publication Date
DK2957280T3 true DK2957280T3 (en)	2019-07-22

Family

ID=54011933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK15001790.3T DK2957280T3 (en)	2014-06-18	2015-06-17	PHARMACEUTICAL SOLID COMPOSITION OF CYTISIN AND PROCEDURES FOR PREPARING THEREOF

Country Status (12)

Country	Link
EP (1)	EP2957280B1 (en)
CY (1)	CY1121986T1 (en)
DK (1)	DK2957280T3 (en)
ES (1)	ES2732711T3 (en)
HR (1)	HRP20191217T1 (en)
HU (1)	HUE044804T2 (en)
LT (1)	LT2957280T (en)
PL (2)	PL408608A1 (en)
PT (1)	PT2957280T (en)
RS (1)	RS58983B1 (en)
SI (1)	SI2957280T1 (en)
TR (1)	TR201909836T4 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201602145D0 (en) *	2016-02-05	2016-03-23	Achieve Pharma Uk Ltd	Salt
EP3598968A1 (en)	2018-07-23	2020-01-29	Adamed Pharma S.A.	Solid pharmaceutical cytisine composition
BG67408B1 (en) *	2019-04-12	2022-01-17	Софарма Ад	Oral drug composition with plant alkaloid for treatment of addictions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2125699B (en)	1982-02-22	1986-02-12	Bruss Ni Sanitarno Gigieniches	Medicinal preparation having antinicotine effect and method for obtention thereof
DK0857172T3 (en)	1996-05-20	2000-03-06	Andrej Zinovyevich Vitik	Phosphorus-containing cytisine derivatives
BG65536B1 (en)	2004-04-16	2008-11-28	"Софарма" Ад	Cytisine-containing medicamentous form
EP2233134A1 (en) *	2009-03-27	2010-09-29	McNeil AB	Multi-portion intra-oral dosage form with organoleptic properties
PL220354B1 (en) *	2012-11-19	2015-10-30	Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością	Solid dosage form comprising micronized cytisine, and a production method thereof

2014
- 2014-06-18 PL PL408608A patent/PL408608A1/en unknown
2015
- 2015-06-17 SI SI201530809T patent/SI2957280T1/en unknown
- 2015-06-17 HU HUE15001790 patent/HUE044804T2/en unknown
- 2015-06-17 EP EP15001790.3A patent/EP2957280B1/en not_active Revoked
- 2015-06-17 LT LTEP15001790.3T patent/LT2957280T/en unknown
- 2015-06-17 PT PT15001790T patent/PT2957280T/en unknown
- 2015-06-17 DK DK15001790.3T patent/DK2957280T3/en active
- 2015-06-17 PL PL15001790T patent/PL2957280T3/en unknown
- 2015-06-17 ES ES15001790T patent/ES2732711T3/en active Active
- 2015-06-17 TR TR2019/09836T patent/TR201909836T4/en unknown
- 2015-06-17 RS RS20190766A patent/RS58983B1/en unknown
2019
- 2019-07-04 HR HRP20191217TT patent/HRP20191217T1/en unknown
- 2019-07-10 CY CY20191100733T patent/CY1121986T1/en unknown

Also Published As

Publication number	Publication date
EP2957280B1 (en)	2019-04-17
PL2957280T3 (en)	2019-09-30
PL408608A1 (en)	2015-12-21
LT2957280T (en)	2019-07-25
ES2732711T3 (en)	2019-11-25
EP2957280A1 (en)	2015-12-23
PT2957280T (en)	2019-07-23
TR201909836T4 (en)	2019-07-22
CY1121986T1 (en)	2020-10-14
RS58983B1 (en)	2019-08-30
SI2957280T1 (en)	2019-08-30
HRP20191217T1 (en)	2019-10-18
HUE044804T2 (en)	2019-11-28

Similar Documents

Publication	Publication Date	Title
DK3204413T3 (en)	2019-12-09	SUBSTANCE OF COMPARATIVE MATERIALS AND METHODS FOR PREPARING AND USING THEREOF
DK3102673T3 (en)	2020-07-06	METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-TALASSEMI
DK3234133T3 (en)	2021-02-08	CRISPR-BASED COMPOSITIONS AND METHODS OF USE
DK3092256T3 (en)	2022-06-20	COMPOUNDS AND COMPOSITIONS FOR IMMUNTERAPHY
DK3212778T3 (en)	2019-11-04	Methods and compositions for stabilizing trans-splicing of intein-modified proteases
DK3096741T3 (en)	2020-09-28	PROCEDURE FOR THE PREPARATION OF HYBRIDOSOMES
DK3200615T3 (en)	2019-08-19	CALORIC-FREE SWEETS AND PROCEDURES FOR SYNTHETIZATION
DK3357513T3 (en)	2023-11-27	PHARMACEUTICAL COMPOSITION AND USE THEREOF
DK3144001T3 (en)	2021-11-15	Compositions of selenoorganic compounds and methods of their use
DK3174858T3 (en)	2019-07-15	PROCEDURE FOR THE PREPARATION OF PYRAZOLS
DK3277270T3 (en)	2021-12-06	COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF ANEMIA
DK3393655T3 (en)	2021-03-15	FENFLURAMIN COMPOSITIONS AND METHODS FOR THE PREPARATION OF THE SAME
DK3204398T3 (en)	2020-06-02	PROCEDURES FOR PHARMACEUTICAL PREPARATION OF GEMCITABIN-PHOSPHATE DIASTEREOISOMER
DK3209696T3 (en)	2021-08-09	METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF GLIOBLASTOM
DK3102184T3 (en)	2019-05-06	STABLE FORMULATIONS OF PEPTIDES AND PROCEDURES FOR PREPARATION
DK2924093T3 (en)	2018-01-29	Multicarboxylate compositions and processes for their preparation
DK3129779T3 (en)	2020-09-07	PROCEDURES AND COMPOSITIONS FOR DETECTING PROFESSIONAL PROTEINS
DK3237054T3 (en)	2019-11-25	Apparatus for the preparation and application of a medical substance
DK3110446T3 (en)	2022-02-28	Methods and compositions for treating Siglec-8-associated diseases
DK3319609T3 (en)	2022-08-22	COMPOSITIONS AND METHODS OF USING ANTIBACTERIAL DRUG COMBINATIONS
DK3380525T3 (en)	2024-01-29	PHARMACEUTICAL FORMULATIONS AND METHODS OF USING THEREOF
DK3495482T3 (en)	2020-10-26	METHOD OF PREPARING DNA UNIT COMPOSITION AND METHOD OF CREATING CONCATENATE DNA
DK3280408T3 (en)	2020-02-03	PROCEDURE FOR THE PREPARATION OF DICYCLOPLATIN
DK3200748T3 (en)	2021-12-13	COMPOSITIONS AND PROCEDURES FOR THE TREATMENT AND PROPHYLAXATION OF INSECTION INFECTIONS
DK3431460T3 (en)	2021-05-10	NEW FORMULATION AND PROCEDURE FOR SYNTHESIS